Audrey Perrotin
Tegeler Str. 7
Berlin, BE 13353, Germany
Berlin, BE 13353, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Experiences from Clinical Research and Routine Use of Florbetaben Amyloid PET-A Decade of Post-Authorization Insights.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 21, 2024
Linking self-perceived cognitive functioning questionnaires using item response theory: The subjective cognitive decline initiative.
Journal: Neuropsychology
Published: June 05, 2023
Association of the Informant-Reported Memory Decline With Cognitive and Brain Deterioration Through the Alzheimer Clinical Continuum.
Journal: Neurology
Published: August 09, 2022
Evaluation of tau deposition using 18F-PI-2620 PET in MCI and early AD subjects-a MissionAD tau sub-study.
Journal: Alzheimer's research & therapy
Published: April 11, 2022
Plasma Levels of Tissue-Type Plasminogen Activator (tPA) in Normal Aging and Alzheimer's Disease: Links With Cognition, Brain Structure, Brain Function and Amyloid Burden.
Journal: Frontiers in aging neuroscience
Published: February 07, 2022
Subjective cognitive decline: opposite links to neurodegeneration across the Alzheimer's continuum.
Journal: Brain communications
Published: March 19, 2021
Early detection of amyloid load using 18F-florbetaben PET.
Journal: Alzheimer's research & therapy
Published: December 23, 2020
Evaluation of Dosimetry, Quantitative Methods, and Test-Retest Variability of 18F-PI-2620 PET for the Assessment of Tau Deposits in the Human Brain.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 06, 2019
Tau PET imaging with 18F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 06, 2019
The role of metamemory on cognitive complaints in cancer patients.
Journal: Brain and behavior
Published: May 17, 2019
The elusive tau molecular structures: can we translate the recent breakthroughs into new targets for intervention?
Journal: Acta neuropathologica communications
Published: December 31, 2018
Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time.
Journal: Alzheimer's research & therapy
Published: December 20, 2018
Last Updated: 09/26/2026